Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest update is out from Mach7 Technologies ( (AU:M7T) ).
Mach7 Technologies has outlined its vision in conjunction with its H1 FY26 results presentation, positioning itself as a provider of a global imaging electronic medical record. By aiming to complete the patient picture with imaging data integrated into EMRs, the company is signaling a strategic focus on interoperability and comprehensive imaging access that could strengthen its role in clinical decision support and enterprise imaging platforms across healthcare systems.
The most recent analyst rating on (AU:M7T) stock is a Hold with a A$0.34 price target. To see the full list of analyst forecasts on Mach7 Technologies stock, see the AU:M7T Stock Forecast page.
More about Mach7 Technologies
Mach7 Technologies, listed on the ASX under ticker M7T, operates in the medical imaging technology sector. The company focuses on building a global imaging electronic medical record, integrating patients’ imaging data into broader clinical records to support healthcare providers and enhance diagnostic workflows.
Average Trading Volume: 300,281
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$79.9M
Learn more about M7T stock on TipRanks’ Stock Analysis page.